Page last updated: 2024-08-23

bisantrene and Neoplasms

bisantrene has been researched along with Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ludwig, C1
Kuhn, JG; Myers, JW; Osborne, CK; Pocelinko, R; Sandbach, JF; Von Hoff, DD1
Clark, GM; Cowan, JD; Von Hoff, DD1
Kuhn, JG; Ludden, TM; Myers, JW; Von Hoff, DD1
Alberts, DS; Mackel, C; Pocelinko, R; Salmon, SE1
Bedikian, AY; Blumenschein, GR; Bodey, GP; Pocelinko, R; Yap, BS; Yap, HY1
Alberts, DS; Dorr, RT; Einspahr, J; Milton, S; Remers, WA; Tunget, CL; Wunz, TP1
Avery, L; Choi, K; Crom, DB; Douglass, EC; Etcubanas, E; Pratt, CB; Sinkule, JA1

Trials

1 trial(s) available for bisantrene and Neoplasms

ArticleYear
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Cancer research, 1982, Volume: 42, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms

1982

Other Studies

7 other study(ies) available for bisantrene and Neoplasms

ArticleYear
Drug resistance of hypoxic tumour cells in vitro.
    Cancer treatment reviews, 1984, Volume: 11 Suppl A

    Topics: Animals; Anthracenes; Cell Line; DNA, Single-Stranded; Drug Evaluation, Preclinical; Drug Resistance; Humans; Hypoxia; Leukemia L1210; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplastic Stem Cells; Stem Cells

1984
Anaphylactoid reactions associated with bisantrene infusions.
    Investigational new drugs, 1983, Volume: 1, Issue:1

    Topics: Anaphylaxis; Anthracenes; Drug Evaluation; Humans; Infusions, Parenteral; Neoplasms

1983
Comparative cytotoxicity of adriamycin, mitoxantrone and bisantrene as measured by a human tumor cloning system.
    Investigational new drugs, 1983, Volume: 1, Issue:2

    Topics: Anthracenes; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Separation; Cell Survival; Clone Cells; Colony-Forming Units Assay; Doxorubicin; Drug Evaluation; Humans; Lymph Nodes; Mitoxantrone; Neoplasms; Tumor Stem Cell Assay

1983
Characterization of the pharmacokinetics of bisantrene (NSC-337766).
    Investigational new drugs, 1983, Volume: 1, Issue:3

    Topics: Aged; Anthracenes; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Humans; Kinetics; Male; Middle Aged; Neoplasms

1983
Phase I clinical evaluation of 9,10-anthracenedicarboxyaldehyde[bis(4,5-dihydro-1H-imidazol-2-yl)hydrazone]dihydrochloride (bisantrene).
    Cancer treatment reports, 1982, Volume: 66, Issue:7

    Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms

1982
New antitumor agents containing the anthracene nucleus.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:8

    Topics: Animals; Anthracenes; Cell Line; Chemical Phenomena; Chemistry; DNA; Humans; Leukemia L1210; Leukemia P388; Mice; Mitoxantrone; Neoplasms; Protein Biosynthesis; RNA; Structure-Activity Relationship

1987
Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumors.
    Investigational new drugs, 1986, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Anthracenes; Child; Child, Preschool; Drug Evaluation; Female; Humans; Male; Metabolic Clearance Rate; Neoplasms

1986